As of 2024-12-11, the Relative Valuation of Promore Pharma AB (PROMO.ST) is (1,034.84) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 9.70 SEK, the upside of Promore Pharma AB based on Relative Valuation is -10768.4%.
The range of the Relative Valuation is (837.20) - (1,089.00) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 30.9x | 30.7x |
| Forward P/E multiples | 21.1x - 30.4x | 27.0x |
| Fair Price | (837.20) - (1,089.00) | (1,034.84) |
| Upside | -8730.9% - -11326.8% | -10768.4% |
| Date | P/E |